WASHINGTON — The Consumer Healthcare Products Association (CHPA) issued the following statement from Scott Melville, president and CEO, in response to the announcement that Patrizia Cavazzoni will succeed Janet Woodcock as the permanent director of the U.S. Food and Drug Administration (FDA) Center for Drug Evaluation and Research: “CHPA congratulates Patrizia Cavazzoni on her recent
WASHINGTON — The Senate on Thursday confirmed California Attorney General Xavier Becerra as President Joe Biden’s health secretary, filling a key position in the administration’s COVID-19 response and its major push to lower drug costs, expand insurance coverage, and eliminate racial disparities in medical care. The 50-49 vote makes the 63-year-old Becerra the first Latino
WASHINGTON — The Consumer Healthcare Products Association (CHPA) issued the following statement regarding the changes in leadership at the FDA Office of Dietary Supplement Programs (ODSP), including Director Steven Tave’s appointment to lead the Office of Regulatory Affairs (ORA) Office of Strategic Planning and Operational Policy, and Dr. Cara Welch’s appointment as Acting Director of
WASHINGTON— Scott Melville, president and CEO of the Consumer Healthcare Products Association (CHPA) applauded the introduction of the Hemp and Hemp-Derived CBD Consumer Protection and Market Stabilization Act of 2021, that was introduced on Thursday. CHPA has also become part of a larger coalition of organizations who support the bill. “We’re encouraged that this legislation
WASHINGTON — The results of the 2020 National Institute on Drug Abuse (NIDA) and University of Michigan’s Monitoring the Future survey shows 3.7% of teens reported using over-the-counter (OTC) cough medicine containing dextromethorphan (DXM) to get high, an increase from 2.8% in 2019. While overall rates remain low, NIDA’s survey release notes that use among eighth
WASHINGTON — The Consumer Healthcare Products Association (CHPA) continued its rebranding effort which began earlier this year with the recent launch of a new flagship website, www.CHPA.org. The association’s new interactive site includes expanded information and resources for the personal healthcare industry — which includes over-the-counter (OTC) medicines, dietary supplements, and consumer medical devices. The
WASHINGTON – The Nature’s Bounty Co., a global leader in health and wellness, has joined the Consumer Healthcare Products Association (CHPA) as its newest member. Nearly half of CHPA’s current members manufacture or market dietary supplements in addition to either over-the-counter (O-T-C) and/or consumer medical device products, but The Nature’s Bounty Co. – a manufacturer
WASHINGTON – The four leading dietary supplement industry associations applaud Representative Kurt Schrader (D, Ore.) and Representative Morgan Griffith (R,Va.), for introducing bipartisan legislation that would protect public health by providing legal clarity in the cannabidiol (CBD) product marketplace. The Hemp and Hemp derived CBD Consumer Protection and Market Stabilization Act of 2020 directs the
WASHINGTON — The Consumer Healthcare Products Association (CHPA) released the following statement Thursday in response to the Trump Administration’s “Buy American” Executive Order (EO) for essential pharmaceuticals: “Over-the-counter (O-T-C) drug manufacturers have been working tirelessly to ensure American consumers have a continued supply of O-T-C medicines to treat a wide variety of ailments, such as
The latest installment in our Video Forum features Scott Melville, president and chief executive officer of the Consumer Healthcare Products Association. In addition to the rebranding of CHPA, Melville talks about what recently enacted O-T-C monograph reform means for the category, and the increasingly important part that nonprescription products are playing in health care.
WASHINGTON — Coming off one of the most significant public policy victories in its 139-year history, the Consumer Healthcare Products Association (CHPA) is updating its brand image and revamping its structure to better reflect the expanding scope of the over-the-counter health care sector. “We asked our members what we want to be, who we want
WASHINGTON— Consumer Healthcare Products Association (CHPA) president and CEO, Scott Melville, issued the following statement upon final passage of the CARES Act, which among its many sections includes provisions to update and modernize the regulatory system overseeing most over-the-counter (O-T-C) medicines and to restore O-T-C eligibility under tax-preferred HSA and FSA accounts. “During this unprecedented
WASHINGTON — The U.S. dietary supplement industry commends the Food and Drug Administration (FDA) for taking action to protect consumers by calling out marketers who make illegal and unsubstantiated drug claims related to COVID-19, the disease caused by the novel coronavirus, SARS-CoV-2. In February, the industry issued strong warning to companies and consumers to avoid
Welcome to 2020, where, more than ever, patients and caregivers are taking control of their health care decisions and an increasing array of consumer health care products is helping them get well, stay healthy, treat minor ailments and even manage some chronic conditions. The marketplace is evolving before our eyes, including the manufacturers, who are
